XML 89 R67.htm IDEA: XBRL DOCUMENT v3.22.4
Income Taxes (Narrative) (Details) - USD ($)
$ in Millions
6 Months Ended 12 Months Ended
Jun. 16, 2022
Dec. 30, 2022
Jun. 16, 2022
Dec. 30, 2022
Dec. 31, 2021
Dec. 25, 2020
Income Tax Contingency [Line Items]            
Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount   $ 4.7 $ (226.5)   $ 224.9 $ 315.3
Increase (Decrease) Tax Expense (Benefit), Change in Operating Income   (30.2) (12.8) $ 92.9    
Current Income Tax Expense (Benefit)   (27.1) (23.9)   (46.4) (375.3)
Increase (Decrease) Tax Benefit, Jurisdiction Rate Difference       (90.4)    
Income Taxes Paid, Net   (3.0) (3.0)   160.0 (39.9)
Deferred Tax Liabilities, Intangible Assets   0.0   0.0 108.5  
Deferred Tax Assets, Other   159.8   159.8 292.2  
Tax loss and credit carryforward   3,646.0   3,646.0 4,147.5  
Unrecognized Tax Benefits, Interest on Income Taxes Accrued   2.8   2.8 18.9  
Unrecognized Tax Benefits that Would Impact Effective Tax Rate $ 24.8 24.8 24.8 24.8 77.0 85.9
Unrecognized Tax Benefits, Interest on Income Taxes Expense   (0.6) (16.7)   (2.2) (16.2)
Tax Credit Carryforward, Amount   1.9   1.9    
Increase (Decrease) Tax Expense (Benefit) due to opioid-related settlement charge       10.6    
Excess in Book over Tax Basis, Foreign Subsidiaries   3.1   3.1    
Deferred Income Tax Expense (Benefit)   (24.9) (473.4)   (59.9) 384.2
(Benefit) expense from income taxes   (52.0) (497.3)   (106.3) 8.9
Deferred Tax Assets, Capital Loss Carryforwards   1,412.6   1,412.6 1,605.0  
Increase (Decrease) Tax Benefit, Medicaid Lawsuit       48.9    
Increase (Decrease) Tax Expense (Benefit) due to reorganization items, net       27.6    
Valuation Allowance Tax Expense         189.7 618.2
Increase (Decrease) Valuation Allowance Tax Expense         428.5  
Increase (Decrease) Valuation Allowance Tax Expense (Benefit), Operational Activity         288.9  
Increase (Decrease) Valuation Allowance Tax Expense (Benefit), deferred tax assets       204.9    
Increase (Decrease) Valuation Allowance Tax Expense (Benefit), tax rate changes       65.3    
Increase (Decrease) Tax Expense (Benefit), Non-restructuring Impairment Charges       13.2    
Deferred Tax Liabilities, Gross   (224.4)   (224.4) (175.6)  
Foreign tax provision, refundable credits           1.0
Foreign Tax Benefit, Carryback Claims           $ 281.5
Increase (Decrease) Tax (Benefit), Inventory Step-Up Amortization   19.7        
Increase (Decrease) Tax Expense (Benefit), Settlement liabilities accretion expense   8.9        
Increase (Decrease) Tax Expense (Benefit), Debt accretion expense   6.3        
Increase (Decrease) Tax Benefit, Fresh-Start adjustments     128.9      
Increase (Decrease) Tax Expense (Benefit), Gain on LSTC adjustments     103.4      
Increase (Decrease) Tax Expense (Benefit), Professional & Lender Fees     18.6      
Increase (Decrease) Tax Expense Benefit, Fresh-Start Accounting Revaluation of DTA 1,202.0          
Increase (Decrease) Income Tax Expense (Benefit), Release of UTP 285.3          
Increase (Decrease) Tax Expense (Benefit), NOL carryforward reduction 1,209.8          
Increase (Decrease) Tax Expense (Benefit), Permanently nondeductible impacts 191.9          
Increase (Decrease) Tax Expense (Benefit), Prepaid income taxes 54.0          
Increase (Decrease) Tax Expense (Benefit), Valuation Allowances     600.8      
Unrecognized Tax Benefits, Period Increase (Decrease)     $ 306.1      
Increase (Decrease) Deferred Tax Assets, Opioid-Related Litigation Settlement Payments       72.8    
Increase (Decrease) Deferred Tax Assets, Intangible Assets Amortization       61.5    
Increase (Decrease) Deferred Tax Assets, Fresh-Start Adjustment       904.5    
Deferred Income Tax Assets, Net   475.5   475.5 0.0  
Deferred income taxes   (0.3)   (0.3) (20.9)  
Deferred income tax asset (liability), net   $ (475.2)   (475.2) $ 20.9  
Increase (Decrease) Deferred Tax Assets, Other       60.6    
IRELAND            
Income Tax Contingency [Line Items]            
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent   12.50% 12.50%   12.50% 12.50%
Nuclear Imaging            
Income Tax Contingency [Line Items]            
(Benefit) expense from income taxes         $ 5.1 $ 18.1
Non-U.K.            
Income Tax Contingency [Line Items]            
Operating Loss Carryforwards 0.1 $ 61.0 $ 0.1 61.0 1.2 33.4
Deferred Tax Assets, Operating Loss Carryforwards   3,600.6   3,600.6    
Deferred Tax Assets, Operating Loss Carryforwards, Not Subject to Expiration   1,532.4   1,532.4    
Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration   2,068.2   2,068.2    
Deferred Tax Assets, Capital Loss Carryforwards   8.7   8.7    
Ireland            
Income Tax Contingency [Line Items]            
Operating Loss Carryforwards 4.1 7.9 4.1 7.9 2.2 $ 0.2
Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration   43.5   43.5    
Deferred Tax Assets, Capital Loss Carryforwards   $ 969.5   $ 969.5    
CARES Act            
Income Tax Contingency [Line Items]            
Proceeds from Income Tax Refunds         178.8  
Operational activity            
Income Tax Contingency [Line Items]            
Income Taxes Paid, Net         $ (18.8)  
Chapter 11 Emergence            
Income Tax Contingency [Line Items]            
(Benefit) expense from income taxes $ 31.6          
Alleviation of Going Concern Substantial Doubt            
Income Tax Contingency [Line Items]            
Increase (Decrease) Tax Expense (Benefit), Valuation Allowances     512.1      
Rate differential between domestic and international jurisdictions            
Income Tax Contingency [Line Items]            
Increase (Decrease) Tax Expense (Benefit), Valuation Allowances     $ 88.7